Literature DB >> 1677702

Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia.

V Falanga1, R S Kirsner, W H Eaglstein, M H Katz, F A Kerdel.   

Abstract

Five consecutive patients with cryofibrinogenaemia in association with painful leg ulcers and intravascular dermal thrombi were treated with stanozolol, an androgenic steroid with fibrinolytic properties. In all patients treatment was followed by rapid and striking pain relief and healing of the ulcers. Cryofibrinogenaemia was not detected on subsequent laboratory evaluation, and dermal intravascular thrombi had resolved on repeat histological examination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677702     DOI: 10.1016/0140-6736(91)90483-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

2.  At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol.

Authors:  E M Yoshida; M A Karim; J F Shaikh; J G Soos; S R Erb
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

3.  Cryofibrinogenaemia: a study of 49 patients.

Authors:  H Blain; P Cacoub; L Musset; N Costedoat-Chalumeau; C Silberstein; O Chosidow; P Godeau; C Frances; J C Piette
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 4.  Chronic wounds.

Authors:  Vincent Falanga; Roslyn Rivkah Isseroff; Athena M Soulika; Marco Romanelli; David Margolis; Suzanne Kapp; Mark Granick; Keith Harding
Journal:  Nat Rev Dis Primers       Date:  2022-07-21       Impact factor: 65.038

5.  Cryofibrinogenaemia: not just skin deep.

Authors:  Zahrae Sandouk; Zaid Alirhayim; Syed Hassan; Waqas Qureshi
Journal:  BMJ Case Rep       Date:  2013-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.